Minerva Neurosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Minerva Neurosciences, Inc. (NERV) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2024-11-05
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-03-31 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-05 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-01 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2024-02-22 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-01 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 0.00% 10-K · filed 2023-03-08 | ||||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-04 | ||||
| 2021-12-31 | 0.00% 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-08 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-02 | ||||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-12 | ||||
| 2020-12-31 | 0.00% 10-K · filed 2021-03-08 | ||||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-02 | ||||
| 2020-06-30 | 0.00% 10-Q · filed 2020-08-03 | ||||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-04 | ||||
| 2019-12-31 | 0.00% 10-K · filed 2020-03-09 | ||||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-04 | ||||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-05 | ||||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-06 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2019-03-12 | ||||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-05 | ||||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-02 | ||||
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-03 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2018-03-12 | ||||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-06 | ||||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-04 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2017-03-13 | ||||
| 2016-09-30 | 0.00% 10-Q · filed 2017-11-06 | ||||
| 2016-06-30 | 0.00% 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-03 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2016-03-14 | ||||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | 0.00% 10-Q · filed 2016-05-03 | ||||
| 2015-02-02 | 0.00% 10-Q · filed 2015-05-07 | ||||
| 2015-01-02 | 0.00% 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | 0.00% 10-K · filed 2016-03-14 | ||||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-05 | ||||
| 2014-07-07 | 0.00% 10-K · filed 2015-03-26 | ||||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |